Biospecimen Management Consortium: Driving Sample Excellence in Clinical Research

About this session

Panel Discussion.

The Biospecimen Management Consortium (BMC) was founded to drive sample excellence in clinical research—by setting standards and developing best practices, streamlining biospecimen operations and data, and shaping regulatory policy. This panel of founding members will discuss the goals and objectives of the consortium, progress on its initiatives, how industry can contribute, and its roadmap for the upcoming year.

Speakers

• 

  Amy Ripston

  Founder & President · Biospecimen Management Consortium

  Moderator

• 

  Karina Bienfait

  Executive Director, Consent, Biospecimen & Imaging Management · Bristol Myers Squibb Co

  Panelist

• 

  Mark Melton

  Panelist

• 

  Roshan Yadama

  Director, Strategic Business Operations · Profound Research

  Panelist